Published on in Vol 10 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/55418, first published .
Geographic Disparities in Access to Assisted Reproductive Technology Centers in China: Spatial-Statistical Study

Geographic Disparities in Access to Assisted Reproductive Technology Centers in China: Spatial-Statistical Study

Geographic Disparities in Access to Assisted Reproductive Technology Centers in China: Spatial-Statistical Study

Research Letter

1School of Public Health and Emergency Management, Southern University of Science and Technology, Shenzhen, China

2Shenzhen Health Development Research and Data Management Center, Shenzhen, China

3Vanke School of Public Health, Tsinghua University, Beijing, China

Corresponding Author:

Bin Zhu, PhD

School of Public Health and Emergency Management

Southern University of Science and Technology

No 1088 Xueyuan Avenue, Nanshan District

Shenzhen, 518055

China

Phone: 86 0755 8801 5610

Email: zhub6@sustech.edu.cn


A study on infertility in China found that while 543 health care institutions are approved for assisted reproductive technology (ART), only 10.1% offer all ART services, with a significant skew toward the eastern regions, highlighting the accessibility challenges faced by rural and remote populations; this study recommends government measures including travel subsidies and education initiatives to improve ART access for economically disadvantaged individuals.

JMIR Public Health Surveill 2024;10:e55418

doi:10.2196/55418

Keywords



Infertility is a growing, serious public health concern [1]. In 2023, the World Health Organization reported that infertility affects about 17.5% of the adult population globally [2]. Infertility is also prominent in China, affecting nearly 50 million people [3]. However, the travel time and costs are often a significant burden faced by patients with infertility [4,5]. Here we used a web path planning engine [6] to explore the spatial-economic disparities in access to assistive reproductive technology (ART) centers in mainland China.


Study Design

The National Health Commission of the People’s Republic of China supplied a list of ART centers, while population data were sourced from the 2020 Worldpop data set [7]. Residential point locations were gathered from the Gaode Maps open platform. After retaining one residential point within a 1-km radius, 57,469 residential points were acquired. We opted for a contemporary approach by leveraging real-time traffic data from web map navigation services—a departure from traditional methods. Using the Path Planning 2.0 algorithm, we determined optimal paths among residential points and the nearest ART center, predicting detailed travel times and corresponding costs [8,9]. We averaged the travel times and costs of residential points within the county, thus representing its overall level. Subsequently, isochronous maps depicting 1-hour and 2-hour travel times for ART services were generated.

Ethical Considerations

This study used deidentified publicly available data sets, all aggregated at the county level. Per Article 3 of the Southern University of Science and Technology’s institutional review board guidelines, we did not require peer review as this is a secondary analysis using publicly accessible locations of ART centers from the National Health Commission’s website and publicly accessible locations of residential points. These data sets contain no personally identifiable information and pose no risk of ethical violation.


As of June 2022, in total, 543 health care institutions in Mainland China have received approved to conduct ART. However, only 55 (10.1%) institutions offer all 5 types of ART services. The distribution of ART centers in China predominantly favors the eastern plains and coastal regions (Figure 1A). Among 7 geographical subregions of China, East China boasts the highest number of ART centers (n=162, 29.8%). Specifically, Guangdong province leads with the greatest number of ART centers (n=56, 10.3%), with 83.9% (n=104) of the province’s counties accessible to ART centers within 1.5 hours and an average taxi cost of merely 66.7 CNY (US $9.21) [10]. In contrast, the Northwest region has the lowest number of ART centers (n=27, 5.0%). Tibet, in particular, has only 1 ART center, and a mere 12.2% (n=9) of Tibetan counties have access to it within 1.5 hours, with taxi costs soaring as high as 1485.2 CNY (US $205.08).

Figure 1. Travel time to assisted reproductive technology (ART) centers in China. (A) A map of travel times to ART centers at the county level. (B) The population density of China's counties covering 1-hour and 2-hour travel time isochrones. Counties with higher population densities are shaded in dark gray. Areas shaded in red are located within the 1-hour and 2-hour travel time isochrones of the ART centers.

Travel time and costs to ART centers by province are presented in Table 1. Detailed information on travel time and costs is visualized in Multimedia Appendix 1. In China, a substantial portion of the population faces challenges in accessing ART facilities within a short time frame. Specifically, 76.8% (n=180,330,033) of the total population and 63.5% (n=36,390) of residential points are not reachable to an ART center within an hour.

Table 1. Travel time and travel costs to assistive reproductive technology (ART) centers by province and proportion of population access to ART services at different time thresholds.
ProvinceART centers, nTravel time (minutes)Cost (CNYa)Population (%)




≤30 minutes≤60 minutes≤120 minutes
North

Beijing1820.852.280.797.7100

Tianjin1222.538.578.793.999.9

Hebei3143.093.144.375.594.1

Shanxi1245.0112.149.265.196.7

Inner Mongolia889.3237.344.055.970.5
Northeast

Heilongjiang1163.0151.352.964.079.3

Jilin972.4153.340.052.377.3

Liaoning1947.590.344.169.494.9
East

Shanghai2017.049.986.999.5100

Jiangsu3338.071.642.983.8100

Zhejiang2740.090.135.581.699.8

Anhui1644.8101.846.263.297.8

Jiangxi1850.4126.941.759.096.1

Shandong3238.190.044.179.5100

Fujian1636.2108.252.283.797.6
Central

Henan3338.866.645.597.399.5

Hunan2452.0121.039.259.895.6

Hubei3239.568.249.572.198.6

Southern






Guangdong5627.766.767.691.299.5

Guangxi2142.3102.053.065.198.0

Hainan1058.3246.150.960.075.1
Southwest

Chongqing1244.9153.044.968.495.6

Guizhou1346.299.949.166.194.4

Sichuan1450.5140.244.670.591.7

Yunnan1869.8199.244.459.177.3

Tibet1267.91485.247.353.058.2
Northwest

Ningxia263.2119.341.961.181.6

Qinghai282.8190.860.277.785.9

Gansu4131.9157.129.532.649.3

Shaanxi1064.6179.238.558.479.3

Xinjiang9108.4275.556.361.567.1

a1CNY=US $0.14. Travel cost was determined by the local taxi fare, which varies depending on the location. The first price covers a specified distance, often 2.5-3 km, and every additional kilometer is then calculated at a certain price.


The distribution of ART centers in China exhibits significant disparities. A higher concentration of ART centers is observed in urban and eastern regions, while individuals in northwestern and rural areas encounter prolonged travel times and elevated transportation costs when seeking ART treatment. The map serves the dual purpose of estimating the likelihood of individuals seeking ART treatment when needed and providing an evidence-based foundation for efficient allocation of limited ART resources to underserved populations (present and future). The government is suggested to implement a series of measures, including counterpart aid and effective initiatives to educate and recruit ART doctors in disadvantaged units. Residents in rural and remote areas contend with extended travel times and substantial travel costs when accessing ART services, which should be covered fully or partially through travel subsidies or paid leaves. The introduction of telehealth services is a viable solution to surmount these barriers for patients residing in remote areas, effectively reducing in-person office visits. Notably, ensuring privacy is paramount when helping patients seeking ART treatments. This study bears limitations. While we used the best available data, the residential point data sets remain susceptible to omission errors, which confines the algorithm’s usage to only 1 mode of transportation—a limitation not potentially aligning with real-world scenarios. Additionally, individuals may not necessarily receive ART treatment at the nearest facility or may opt for alternative transportation means.

Acknowledgments

This study is funded by the Guangdong Philosophy and Social Sciences Planning Project (GD22YGL10), Shenzhen Philosophy and Social Sciences Planning Project (SZ2023C007), and Shenzhen Science and Technology Program (JCYJ20220530113208019). The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

Authors' Contributions

BZ had full access to all of the study data and takes responsibility for the integrity of the data and the accuracy of the data analysis. BZ conceptualized and designed the study; acquired the data; obtained the funding; provided administrative, technical, or material support; and supervised the study. QZ carried out the statistical analysis and drafted the manuscript. QZ and BZ interpreted the data. HZ, LW, KD, RH, and BZ critically revised the manuscript for important intellectual content.

Conflicts of Interest

None declared.

Multimedia Appendix 1

Travel time and cost analyses.

DOCX File , 12259 KB

  1. Liu X, Deng Y, Chen P, Liu C, Miao Y, Zhang M, et al. Self-rated health and semen quality in men undergoing assisted reproductive technology. JAMA Netw Open. Jan 02, 2024;7(1):e2353877. [FREE Full text] [CrossRef] [Medline]
  2. Infertility prevalence estimates (1990-2021). World Health Organization. 2023. URL: https://www.who.int/publications/i/item/978920068315 [accessed 2024-05-28]
  3. Shao F, He Z, Zhu Z, Wang X, Zhang J, Shan J, et al. Internet influence of assisted reproduction technology centers in China: qualitative study based on WeChat official accounts. J Med Internet Res. Jun 10, 2020;22(6):e17997. [FREE Full text] [CrossRef] [Medline]
  4. Harris JA, Menke MN, Haefner JK, Moniz MH, Perumalswami CR. Geographic access to assisted reproductive technology health care in the United States: a population-based cross-sectional study. Fertil Steril. Apr 2017;107(4):1023-1027. [FREE Full text] [CrossRef] [Medline]
  5. Peipert BJ, Potapragada NR, Lantos PM, Harris BS, Reinecke J, Goldman KN. A geospatial analysis of disparities in access to oncofertility services. JAMA Oncol. Oct 01, 2023;9(10):1364-1370. [CrossRef] [Medline]
  6. García-Albertos P, Picornell M, Salas-Olmedo MH, Gutiérrez J. Exploring the potential of mobile phone records and online route planners for dynamic accessibility analysis. Transport Res A-Pol Pract. Jul 2019;125:294-307. [FREE Full text] [CrossRef]
  7. Chen L, Zeng H, Wu L, Tian Q, Zhang N, He R, et al. Spatial accessibility evaluation and location optimization of primary healthcare in China: a case study of Shenzhen. GeoHealth. May 16, 2023;7(5):A. [FREE Full text] [CrossRef]
  8. Zheng Z, Xia H, Ambinakudige S, Qin Y, Li Y, Xie Z, et al. Spatial accessibility to hospitals based on web mapping API: an empirical study in Kaifeng, China. Sustainability. Feb 22, 2019;11(4):1160. [FREE Full text] [CrossRef]
  9. Zheng Z, Shen W, Li Y, Qin Y, Wang L. Spatial equity of park green space using KD2SFCA and web map API: a case study of Zhengzhou, China. Appl Geogr. Oct 2020;123:102310. [FREE Full text] [CrossRef]
  10. Zhang J, Ding S, Hu X. Analysis of spatial and temporal impact differences of birth rate in mainland China. Sci Rep. Oct 17, 2022;12(1):17396. [FREE Full text] [CrossRef] [Medline]


ART: assisted reproductive technology


Edited by A Mavragani, T Sanchez; submitted 12.12.23; peer-reviewed by C Song, SJC Soerensen; comments to author 16.01.24; revised version received 04.02.24; accepted 08.05.24; published 12.06.24.

Copyright

©Qingqing Zhou, Huatang Zeng, Liqun Wu, Kaichuan Diao, Rongxin He, Bin Zhu. Originally published in JMIR Public Health and Surveillance (https://publichealth.jmir.org), 12.06.2024.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Public Health and Surveillance, is properly cited. The complete bibliographic information, a link to the original publication on https://publichealth.jmir.org, as well as this copyright and license information must be included.